In the wake of the coronavirus spreading, the Association for Accessible Medicines said it will work to help ensure that patients in the United States get access to generic and biosimilar medicines.
ProAir HFA — one of the most commonly used rescue inhalers in the country — had a market value of approximately $1.4 billion for the previous 12 months, according to IQVIA.
The AAM and Biosimilars Council said it will continue to call on policymakers to support legislation that would require all patents for the reference biologic to be listed in the FDA's Purple Book.